| Mucor in a Viral Land: A Tale of Two Pathogens | Indian Journal of Ophthalmology | 2021 | 148 |
| Acute Invasive Rhino-Orbital Mucormycosis in a Patient With COVID-19-Associated Acute Respiratory Distress Syndrome | Ophthalmic Plastic and Reconstructive Surgery | 2021 | 109 |
| Progression of Myopia in School-Aged Children After COVID-19 Home Confinement | JAMA Ophthalmology | 2021 | 88 |
| Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1 | Indian Journal of Ophthalmology | 2021 | 88 |
| Digital Screen Time During the COVID-19 Pandemic: Risk for a Further Myopia Boom? | American Journal of Ophthalmology | 2021 | 87 |
| COVID-19 and orbital mucormycosis | Indian Journal of Ophthalmology | 2021 | 87 |
| COVID-19 and Eye: A Review of Ophthalmic Manifestations of COVID-19 | Indian Journal of Ophthalmology | 2021 | 85 |
| Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis | Ophthalmology | 2021 | 78 |
| Global contact lens wear and purchase behaviour during COVID-19 times | Contact Lens and Anterior Eye | 2021 | 78 |
| Resident Perspectives 56–1 | Canadian Journal of Ophthalmology | 2021 | 78 |
| Impact of COVID-19 on mental health in eye care professionals, staff and students | Journal of AAPOS | 2021 | 78 |
| Impact of socioeconomic factors in access to care in pediatric ophthalmology during the COVID-19 pandemic | Journal of AAPOS | 2021 | 78 |
| Trends in pediatric ocular trauma presenting to an ophthalmology-specific emergency department during the COVID-19 pandemic | Journal of AAPOS | 2021 | 78 |
| 2021: private equity and ophthalmology in the era of COVID-19 | Journal of AAPOS | 2021 | 78 |
| Toxic epidermal necrolysis triggered by COVID-19 | Journal of AAPOS | 2021 | 78 |
| Drive-thru children eye screening using a vision screening device in response to COVID-19 in Indonesia | Journal of AAPOS | 2021 | 78 |
| The strength of rebound: patient care and financial consequences of COVID-19 in U.S. pediatric ophthalmology | Journal of AAPOS | 2021 | 78 |
| HAWK and HARRIER: Ninety-Six-Week Outcomes from the Phase 3 Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration | Ophthalmology | 2021 | 73 |
| Co-expression of SARS-CoV-2 entry genes in the superficial adult human conjunctival, limbal and corneal epithelium suggests an additional route of entry via the ocular surface | Ocular Surface | 2021 | 71 |
| C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial | Ophthalmology | 2021 | 70 |
| Rise of the phoenix: Mucormycosis in COVID-19 times | Indian Journal of Ophthalmology | 2021 | 70 |
| Digital technology, tele-medicine and artificial intelligence in ophthalmology: A global perspective | Progress in Retinal and Eye Research | 2021 | 63 |
| Optical coherence tomography angiography analysis of the retina in patients recovered from COVID-19: a case-control study | Canadian Journal of Ophthalmology | 2021 | 62 |
| Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report | European Journal of Ophthalmology | 2021 | 58 |
| Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER | Ophthalmology | 2021 | 55 |
